RxDoctor Payments Data

Nicholas Renaldo, MD

Orthopaedic Surgery of the Spine · Poughkeepsie, NYNPI 1750619029

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (58.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Precision Spine, Inc. accounts for 80.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $61,028 and has fallen 66.1% since, to $20,702 in 2025. Among orthopaedic surgery of the spine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$255,268in general payments, 2019–2025

Across 231 payments — averaging $1105.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Precision Spine, Inc.$206K
  • 4web, Inc.$25K
  • Globus Medical$17K
  • Misonix Inc$2K
  • Medtronic$1K
  • Arthrex$1K
  • plus $3K from 12 others

What the payments were for

  • Royalty or licence$149,79259%
  • Consulting fees$92,96136%
  • Travel & lodging$5,6232%
  • Food & beverage$6,8923%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$255,268 in reported general payments places this provider in the 90th percentile of 161 orthopaedic surgery of the spine providers in New York.

See all orthopaedic surgery of the spine providers in New York

Medicare billing

Part B allowed, 2024
$273,422
Medicare patients
596
Services billed
1,697

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam379$972
Cyclobenzaprine Hcl162$573
Methylprednisolone68$510
Gabapentin120$484
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen37$281
Tramadol Hcl94$249
Mupirocin45$234
Naproxen21$101
Oxycodone Hcl18$54
Diazepam16$40

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Poughkeepsie

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →